Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABA_A receptor α2β2γ2S subtype is a pentameric ligand-gated chloride channel that serves as a primary mediator of fast inhibitory neurotransmission in the central nervous system [1, 2]. It is typically composed of two α2, two β2, and one γ2S (short splice variant) subunits, forming a central pore that opens upon the binding of the neurotransmitter gamma-aminobutyric acid (GABA) [1, 5]. This specific subtype is highly expressed in brain regions such as the amygdala and hippocampus, where it plays a critical role in modulating emotional states, anxiety, and the brain's reward system [6, 11]. Pharmacologically, it is a major target for benzodiazepines, which act as positive allosteric modulators at the α/γ subunit interface to enhance GABAergic inhibition [4, 9]. Dysregulation or genetic variations of this receptor are linked to various neuropsychiatric conditions, including generalized anxiety disorder, epilepsy, and chronic pain [11, 12]. Consequently, it is a significant focus for the development of subtype-selective therapies aimed at providing anxiolytic and anticonvulsant effects with reduced sedative side effects compared to non-selective modulators [12, 13].
Positive allosteric modulation of the chloride channel in response to GABA binding, increasing the frequency or duration of channel opening to induce membrane hyperpolarization.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-2 beta-2 gamma-2S subtype (GABA_A receptor α2β2γ2S).